In a report released on May 21, Brad Heffern from RBC Capital maintained a Hold rating on AvalonBay, with a price target of $188.00. The company’s ......

AvalonBay ( ($AVB) ) has shared an announcement. At its Annual Meeting held on May 20, 2026, AvalonBay stockholders re-elected 12 directors to serv......

There’s a lot to be optimistic about in the Real Estate sector as 2 analysts just weighed in on AvalonBay (AVB) and Sun Communities (SUI) with bull......

U.S. bank First Carolina has filed for a New York IPO amid growing investor interest in the financial sector. First Carolina Coming to New York The......

Companies in the Real Estate sector have received a lot of coverage today as analysts weigh in on AvalonBay (AVB) and Jones Lang Lasalle (JLL). Ava......

An update from Avidbank Holdings ( ($AVBH) ) is now available. Avidbank Holdings, Inc. held its 2026 Annual Meeting of Shareholders on May 19, 2026......

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Climb Bio (CLYM) and ArriVent BioPharma, Inc. (AVBP)......

LifeSci Capital analyst Sam Slutsky maintained a Buy rating on ArriVent BioPharma, Inc. yesterday and set a price target of $42.00. According to Ti......

Morgan Stanley analyst Adam Kramer maintained a Hold rating on AvalonBay today and set a price target of $205.00. Kramer covers the Real Estate sec......

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Harrow Health (HROW), Hims & Hers Health (HIMS) and ArriVent BioP......